piracetam has been researched along with Genetic Predisposition in 7 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam (LEV), a newer antiepileptic drug (AED) useful for several epilepsy syndromes, binds to SV2A." | 7.75 | No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy. ( Cavalleri, GL; Delanty, N; Depondt, C; Doherty, CP; Goldstein, DB; Kinirons, P; Lynch, JM; Murphy, K; O'Rourke, D; Sander, JW; Shianna, KV; Sisodiya, SM; Tate, SK; Weale, ME; Wood, NW, 2009) |
| "Levetiracetam (LEV), a newer antiepileptic drug (AED) useful for several epilepsy syndromes, binds to SV2A." | 3.75 | No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy. ( Cavalleri, GL; Delanty, N; Depondt, C; Doherty, CP; Goldstein, DB; Kinirons, P; Lynch, JM; Murphy, K; O'Rourke, D; Sander, JW; Shianna, KV; Sisodiya, SM; Tate, SK; Weale, ME; Wood, NW, 2009) |
| "Levetiracetam (LEV) is a highly effective antiepileptic agent." | 2.49 | Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam. ( Elger, CE; Helmstaedter, C; Hurlemann, R; Kunz, WS; Mihov, Y; Nuernberg, P; Schoch, S; Surges, R; Thiele, H; Toliat, MR, 2013) |
| "Levetiracetam (LEV) treatment was started in combination with VPA in a patient with typical clinical, histological, and biochemical features of MERRF due to a mutation on the tRNA of Phenilalanine gene." | 1.33 | Antimyoclonic effect of levetiracetam in MERRF syndrome. ( Filosto, M; Galli, R; Mancuso, M; Murri, L; Pizzanelli, C; Siciliano, G, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, KH | 1 |
| Song, JS | 1 |
| Park, CW | 1 |
| Ki, CS | 1 |
| Heo, K | 1 |
| Lynch, JM | 1 |
| Tate, SK | 1 |
| Kinirons, P | 1 |
| Weale, ME | 1 |
| Cavalleri, GL | 1 |
| Depondt, C | 1 |
| Murphy, K | 1 |
| O'Rourke, D | 1 |
| Doherty, CP | 1 |
| Shianna, KV | 1 |
| Wood, NW | 1 |
| Sander, JW | 1 |
| Delanty, N | 1 |
| Goldstein, DB | 1 |
| Sisodiya, SM | 1 |
| Ishimaru, Y | 1 |
| Chiba, S | 1 |
| Serikawa, T | 1 |
| Sasa, M | 1 |
| Inaba, H | 1 |
| Tamura, Y | 1 |
| Ishimoto, T | 1 |
| Takasaki, H | 1 |
| Sakamoto, K | 1 |
| Yamaguchi, K | 1 |
| Surina, NM | 1 |
| Kalinina, TS | 1 |
| Volkova, AV | 1 |
| Malikova, LA | 1 |
| Poletaeva, II | 1 |
| Rayevsky, KS | 1 |
| Fedotova, IB | 1 |
| Helmstaedter, C | 1 |
| Mihov, Y | 1 |
| Toliat, MR | 1 |
| Thiele, H | 1 |
| Nuernberg, P | 1 |
| Schoch, S | 1 |
| Surges, R | 1 |
| Elger, CE | 1 |
| Kunz, WS | 1 |
| Hurlemann, R | 1 |
| Mancuso, M | 1 |
| Galli, R | 1 |
| Pizzanelli, C | 1 |
| Filosto, M | 1 |
| Siciliano, G | 1 |
| Murri, L | 1 |
| Coban, A | 1 |
| Gurses, C | 1 |
| Bilgic, B | 1 |
| Sencer, S | 1 |
| Karasu, A | 1 |
| Bebek, N | 1 |
| Baykan, B | 1 |
| Hepgul, KT | 1 |
| Gokyigit, A | 1 |
1 review available for piracetam and Genetic Predisposition
| Article | Year |
|---|---|
Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam.
Topics: Adult; Aggression; Anticonvulsants; Catechol O-Methyltransferase; Dopamine; Dopamine beta-Hydroxylas | 2013 |
6 other studies available for piracetam and Genetic Predisposition
| Article | Year |
|---|---|
First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea.
Topics: Adult; Anticonvulsants; Blotting, Southern; Cystatin B; Female; Genetic Predisposition to Disease; H | 2018 |
No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy.
Topics: Adult; Anticonvulsants; Cohort Studies; Epilepsy; Epilepsy, Temporal Lobe; Female; Genetic Predispos | 2009 |
Effects of levetiracetam on hippocampal kindling in Noda epileptic rats.
Topics: Animals; Anticonvulsants; Brain Stem; Disease Models, Animal; Disease Progression; Drug Administrati | 2010 |
Anxiety and predisposition to audiogenic epilepsy in rats of different genotypes.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Benzimidazoles; Epilepsy, Reflex; Genetic Pr | 2011 |
Antimyoclonic effect of levetiracetam in MERRF syndrome.
Topics: Activities of Daily Living; Anticonvulsants; Atrophy; Brain; Drug Therapy, Combination; Female; Gene | 2006 |
Sporadic multiple cerebral cavernomatosis: report of a case and review of literature.
Topics: Adult; Anticonvulsants; Brain; Cerebral Hemorrhage; Chromosomes, Human, Pair 7; Epilepsy; Family Hea | 2008 |